Cincinnati, Ohio – The University of Cincinnati Cancer Center is the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer. According to the National Cancer Institute, more than 66,000 Americans will be diagnosed with pancreatic cancer in 2024....
Latest News
San Diego, Ca – University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Hematology (ASH) Annual Meeting, held Dec. 9-12 in San Diego, California. Trial finds new drug shows promise to treat Chronic Lymphocytic Leukemia (CLL) Phase 2 clinical trial results suggest a new drug...
Cincinnati, OH – While the overall cancer death rate has been steadily declining in the U.S. since the 1990s, death rates due to pancreatic cancer are increasing. This is especially true in pancreatic cancer that has metastasized, or spread to a different part of the body. The National Cancer Institute...
Cincinnati, Ohio – While better screening and improved treatments are leading to better outcomes for patients with breast cancer, 90% of breast cancer deaths are a result of metastasis, or the cancer growing and spreading to other parts of the body. University of Cincinnati Cancer Center researchers in the lab...
Coimbra, Portugal – The body’s inability to produce enough insulin or use it effectively often results in type 2 diabetes (T2D), a chronic disease affecting hundreds of millions of people around the globe. Disease management is crucial to avoid negative long-term outcomes, such as limb amputation or heart disease. To...
Cologne, Germany – A team of researchers from the University of Cologne’s Faculty of Medicine and University Hospital Cologne, led by Dr Yuri Tolkach and Professor Dr Reinhard Büttner, has created a digital pathology platform based on artificial intelligence. The platform uses new algorithms developed by the team and enables...
Cologne, Germany – In the treatment of aggressive lymphomas and blood cancer (leukaemia), so-called chimeric antigen receptor T cells (CAR T cells) are increasingly being used. For this therapy, immune cells are taken from patients and programmed by means of genetic engineering to detect proteins on the malignant tumour cells....
Boulder, Colorado – Peek inside the human genome and, among the 20,000 or so genes that serve as building blocks of life, you’ll also find flecks of DNA left behind by viruses that infected primate ancestors tens of millions of years ago. These ancient hitchhikers, known as endogenous retroviruses, were...
Aurora, Colorado – A partnership between ophthalmology researchers at the University of Colorado School of Medicine and Johns Hopkins University expands the understanding of how oxidative stress contributes to the development of choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD). To study the roles oxidative stress, a...
Norwich, England – Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer which could revolutionise how the disease is diagnosed and treated in the future. A Cancer Research UK-funded study published today, reveals that prostate cancer, which affects one in eight men in their lifetime, includes...